New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Three-minute test detects common form of dementia that's hard to diagnose

Three-minute test detects common form of dementia that's hard to diagnose

by Florida Atlantic UniversityJames E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, and a professor in FAU's Charles E. Schmidt College of Medicine and Chri
Neurology February 26,2024
Three-minute test detects common form of dementia that's hard to diagnose

Three-minute test detects common form of dementia that's hard to diagnose

by Florida Atlantic UniversityJames E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, and a professor in FAU's Charles E. Schmidt College of Medicine and Chri
Neurology February 26,2024
Neurological research provides molecular insights into the blood–brain barrier

Neurological research provides molecular insights into the blood–brain barrier

by Liu Jia,Chinese Academy of SciencesGraphical abstract of this study. Credit: Prof. Chang, fromCell Reports(2023). DOI: 10.1016/j.celrep.2023.113392A team of researchers from the S
Neurology February 26,2024
Neurological research provides molecular insights into the blood–brain barrier

Neurological research provides molecular insights into the blood–brain barrier

by Liu Jia,Chinese Academy of SciencesGraphical abstract of this study. Credit: Prof. Chang, fromCell Reports(2023). DOI: 10.1016/j.celrep.2023.113392A team of researchers from the S
Neurology February 26,2024
Yeast protein could offer clues to how Alzheimer's plaques form in the brain

Yeast protein could offer clues to how Alzheimer's plaques form in the brain

by Anne Trafton,Massachusetts Institute of TechnologyMIT biologists found that the yeast protein Rim4 forms disordered clumps similar to the beta-amyloid plaques associated with Alzheimer’s dise
Neurology February 26,2024
Yeast protein could offer clues to how Alzheimer's plaques form in the brain

Yeast protein could offer clues to how Alzheimer's plaques form in the brain

by Anne Trafton,Massachusetts Institute of TechnologyMIT biologists found that the yeast protein Rim4 forms disordered clumps similar to the beta-amyloid plaques associated with Alzheimer’s dise
Neurology February 26,2024
Reducing harmful proteins in the fight against dementia

Reducing harmful proteins in the fight against dementia

by Jacqueline Pumphrey, Oxford Science Blog,Oxford UniversityWe probably all know someone who has dementia. By 2025, there will be 1 million people affected by it in the UK. Alzheimer's dise
Neurology February 26,2024
Reducing harmful proteins in the fight against dementia

Reducing harmful proteins in the fight against dementia

by Jacqueline Pumphrey, Oxford Science Blog,Oxford UniversityWe probably all know someone who has dementia. By 2025, there will be 1 million people affected by it in the UK. Alzheimer's dise
Neurology February 26,2024
Smart emergency scheme for people with dementia

Smart emergency scheme for people with dementia

by Karlsruhe Institute of TechnologyThe QuartrBack project is to enable social inclusion and freedom of movement in familiar surroundings for people with dementia. Credit: Alexandr Mitiuc / fotal
Neurology February 26,2024
Smart emergency scheme for people with dementia

Smart emergency scheme for people with dementia

by Karlsruhe Institute of TechnologyThe QuartrBack project is to enable social inclusion and freedom of movement in familiar surroundings for people with dementia. Credit: Alexandr Mitiuc / fotal
Neurology February 26,2024
Study reveals new link between Down syndrome and Alzheimer's

Study reveals new link between Down syndrome and Alzheimer's

by Temple UniversityDomenico Praticò, M.D. Credit: The Lewis Katz School of Medicine at Temple UniversityIndividuals with Down syndrome who survive into adulthood face the additional challenge of
Neurology February 26,2024
Study reveals new link between Down syndrome and Alzheimer's

Study reveals new link between Down syndrome and Alzheimer's

by Temple UniversityDomenico Praticò, M.D. Credit: The Lewis Katz School of Medicine at Temple UniversityIndividuals with Down syndrome who survive into adulthood face the additional challenge of
Neurology February 26,2024
Study looks at whether daily limb compressions reduce dementia

Study looks at whether daily limb compressions reduce dementia

by Medical College of GeorgiaDr. David Hess is Chairman of the Department of Neurology at the Medical College of Georgia at Georgia Regents University. Credit: Phil JonesA new study is looking at
Neurology February 26,2024
Study looks at whether daily limb compressions reduce dementia

Study looks at whether daily limb compressions reduce dementia

by Medical College of GeorgiaDr. David Hess is Chairman of the Department of Neurology at the Medical College of Georgia at Georgia Regents University. Credit: Phil JonesA new study is looking at
Neurology February 26,2024
Breakthrough research reveals a new target for Alzheimer's disease treatment

Breakthrough research reveals a new target for Alzheimer's disease treatment

by VIB (the Flanders Institute for Biotechnology)A 3D visualization of lectin-stained blood vessels (magenta) and Thioflavin-S–positive (yellow) amyloid plaques in the brain of a mouse model of A
Neurology February 26,2024
Breakthrough research reveals a new target for Alzheimer's disease treatment

Breakthrough research reveals a new target for Alzheimer's disease treatment

by VIB (the Flanders Institute for Biotechnology)A 3D visualization of lectin-stained blood vessels (magenta) and Thioflavin-S–positive (yellow) amyloid plaques in the brain of a mouse model of A
Neurology February 26,2024
Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

by Indiana UniversityLeft hemisphere of J. Piłsudski's brain, lateral view. Credit: public domainIn a newly published study, a multi-institutional team led by scientists at the Indiana Univer
Neurology February 26,2024
Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

by Indiana UniversityLeft hemisphere of J. Piłsudski's brain, lateral view. Credit: public domainIn a newly published study, a multi-institutional team led by scientists at the Indiana Univer
Neurology February 26,2024
Brain differences seen in young adults at genetic risk of Alzheimer's

Brain differences seen in young adults at genetic risk of Alzheimer's

by Amy Norton, Healthday ReporterGenetic risk for Alzheimer’s disease is linked to reduced grid-cell-like representations during virtual navigation. Credit: Created by bureaublauwgeel.nl, commissioned
Neurology February 26,2024
Brain differences seen in young adults at genetic risk of Alzheimer's

Brain differences seen in young adults at genetic risk of Alzheimer's

by Amy Norton, Healthday ReporterGenetic risk for Alzheimer’s disease is linked to reduced grid-cell-like representations during virtual navigation. Credit: Created by bureaublauwgeel.nl, commissioned
Neurology February 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com